US2444570A
(en)
|
|
1948-07-06 |
|
Drive for counter numeral wheels |
GB735443A
(en)
|
1952-09-02 |
1955-08-24 |
English Numbering Machines |
Improvements in or relating to counting devices
|
US2828742A
(en)
|
1957-05-02 |
1958-04-01 |
American Home Prod |
Cartridge-needle unit
|
NL300399A
(fr)
|
1963-05-02 |
|
|
|
US3318289A
(en)
|
1965-05-11 |
1967-05-09 |
Northern Ind Products |
Bi-stable mechanism
|
CH499734A
(de)
|
1968-07-19 |
1970-11-30 |
Kienzle Apparate Gmbh |
Klinkengesperre als Einrichtungs- und Überholkupplung
|
US3758683A
(en)
|
1971-04-30 |
1973-09-11 |
R Jackson |
Insulin product
|
US4282316A
(en)
|
1979-09-11 |
1981-08-04 |
Modrovich Ivan Endre |
Stabilized enzymic solutions for determining urea
|
PT72703B
(en)
|
1980-03-21 |
1982-11-15 |
Wellcome Found |
Stabilised ophtalmic formulation
|
US4425346A
(en)
|
1980-08-01 |
1984-01-10 |
Smith And Nephew Associated Companies Limited |
Pharmaceutical compositions
|
IE52621B1
(en)
|
1981-02-12 |
1988-01-06 |
Turner Robert Charles |
Dose metering plunger devices for use with syringes
|
US4568335A
(en)
|
1981-08-28 |
1986-02-04 |
Markwell Medical Institute, Inc. |
Device for the controlled infusion of medications
|
DE3204178C2
(de)
|
1982-02-06 |
1986-03-20 |
Eppendorf Gerätebau Netheler + Hinz GmbH, 2000 Hamburg |
Pipettiervorrichtung
|
US4483849A
(en)
|
1983-01-07 |
1984-11-20 |
Carter William A |
Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product
|
US4498788A
(en)
|
1983-06-03 |
1985-02-12 |
Diehl Gmbh & Co. |
Escapement for a timer
|
EP0143895B1
(fr)
|
1983-09-07 |
1987-12-23 |
Disetronic Ag |
Dispositif portatif d'infusion
|
US4468346A
(en)
|
1983-10-27 |
1984-08-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
Monoclonal antibodies to porcine immunoglobulins
|
JPS60129941U
(ja)
|
1984-02-09 |
1985-08-31 |
テルモ株式会社 |
医療用器具
|
US4592745A
(en)
|
1984-02-29 |
1986-06-03 |
Novo Industri A/S |
Dispenser
|
FR2583291A1
(fr)
|
1985-06-14 |
1986-12-19 |
Hazon Bernard |
Dispositif d'avancement pas a pas du piston de seringues par double vis coaxiale avec controle du debit d'injection. application aux injections medicamenteuses intra-dermiques repetitives
|
DE3546150A1
(de)
|
1985-06-24 |
1987-01-22 |
Hoechst Ag |
Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
|
WO1987002895A1
(fr)
|
1985-11-08 |
1987-05-21 |
Disetronic Ag |
Instrument d'injection
|
DE3609555A1
(de)
|
1986-03-21 |
1987-09-24 |
Josef Porner |
Blutentnahmespritze
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
ATE110083T1
(de)
|
1986-05-05 |
1994-09-15 |
Gen Hospital Corp |
Insulinotropes hormon.
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
US4917685A
(en)
|
1986-05-16 |
1990-04-17 |
International Minerals & Chem. Corp. |
Delivery device for the administration of stabilized growth promoting hormones
|
DE3638984C3
(de)
|
1986-11-14 |
1993-11-18 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
US5716990A
(en)
|
1987-03-09 |
1998-02-10 |
Cancer Research Campaign Technology Limited |
Drug delivery systems
|
DK177187A
(da)
|
1987-04-07 |
1988-10-08 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glasampul
|
DE3715258C2
(de)
|
1987-05-08 |
1996-10-31 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
EP0368864B1
(fr)
|
1987-05-14 |
1993-11-03 |
Commonwealth Scientific And Industrial Research Organisation |
Fractions proteiques de petit lait
|
GB8713810D0
(en)
|
1987-06-12 |
1987-07-15 |
Hypoguard Uk Ltd |
Measured dose dispensing device
|
FI883338A
(fi)
|
1987-07-16 |
1989-01-17 |
Bristol Myers Co |
Vattenloesningar av doxorubicinhydroklorid.
|
IT1222331B
(it)
|
1987-08-25 |
1990-09-05 |
Bruno Micovilovich |
Siringa di sicurezza per usi parentali,a disimpegno autonomo e rapido dell'ago dopo l'uso
|
US4919596A
(en)
|
1987-12-04 |
1990-04-24 |
Pacesetter Infusion, Ltd. |
Fluid delivery control and monitoring apparatus for a medication infusion system
|
US4833379A
(en)
|
1988-01-13 |
1989-05-23 |
Sherwood Medical Company |
Motor control fail-safe circuit
|
CH675078A5
(fr)
|
1988-01-22 |
1990-08-31 |
Nosta Ag |
|
DE3900926C2
(de)
|
1988-02-08 |
1999-05-12 |
Disetronic Licensing Ag |
Spritzenförmiges Injektionsgerät und Injektionsgerätebaukasten
|
US4973318A
(en)
|
1988-02-10 |
1990-11-27 |
D.C.P. Af 1988 A/S |
Disposable syringe
|
DK166948B1
(da)
|
1988-02-10 |
1993-08-09 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glastubule
|
JPH03505401A
(ja)
|
1988-06-27 |
1991-11-28 |
ジェネックス・コーポレーション |
組換えタンパク質の培養培地への熱放出
|
DE58908873D1
(de)
|
1988-09-12 |
1995-02-23 |
Graesslin Kg |
Richtgesperre für eine Schaltuhr.
|
GB8900763D0
(en)
|
1989-01-13 |
1989-03-08 |
Kabi Vitrum Peptide Hormones A |
Multi-dose syringe
|
US5216437A
(en)
|
1989-02-02 |
1993-06-01 |
Canon Kabushiki Kaisha |
Ink, and recording method making use of same
|
DK68789A
(da)
|
1989-02-14 |
1990-08-15 |
Novo Nordisk As |
Injektionspen
|
HU203372B
(en)
|
1989-02-24 |
1991-07-29 |
Richter Gedeon Vegyeszet |
Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
|
JPH04504246A
(ja)
|
1989-03-20 |
1992-07-30 |
ザ・ジェネラル・ホスピタル・コーポレーション |
インシュリン刺激ホルモン
|
JP2822447B2
(ja)
|
1989-05-19 |
1998-11-11 |
住友電気工業株式会社 |
酸化物超電導線材の製造方法および装置
|
US4994033A
(en)
|
1989-05-25 |
1991-02-19 |
Schneider (Usa) Inc. |
Intravascular drug delivery dilatation catheter
|
US5226895A
(en)
|
1989-06-05 |
1993-07-13 |
Eli Lilly And Company |
Multiple dose injection pen
|
DE3927286C2
(de)
|
1989-08-18 |
1997-07-24 |
Roehm Gmbh |
Wäßrige Enzym-Flüssigformulierungen
|
US5216011A
(en)
|
1989-09-01 |
1993-06-01 |
Bristol-Myers Squibb Co. |
Stable solutions of mitomycin c
|
DE69013471T2
(de)
|
1989-12-05 |
1995-03-30 |
Merck & Co Inc |
Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
|
DK17890A
(da)
|
1990-01-22 |
1991-07-23 |
Novo Nordisk As |
Fremgangsmaade og apparat til opblanding og injicering af et laegemiddel
|
JP3262329B2
(ja)
|
1990-01-24 |
2002-03-04 |
アイ. バックレイ,ダグラス |
糖尿病治療に有用なglp―1アナログ
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
DE4002066A1
(de)
|
1990-01-25 |
1991-08-01 |
Basf Ag |
Verfahren zur abtrennung von riboflavin aus fermentationssuspensionen
|
GB9007113D0
(en)
|
1990-03-29 |
1990-05-30 |
Sams Bernard |
Dispensing device
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
US5318540A
(en)
|
1990-04-02 |
1994-06-07 |
Pharmetrix Corporation |
Controlled release infusion device
|
US5492534A
(en)
|
1990-04-02 |
1996-02-20 |
Pharmetrix Corporation |
Controlled release portable pump
|
US5226896A
(en)
|
1990-04-04 |
1993-07-13 |
Eli Lilly And Company |
Dose indicating injection pen
|
IT220491Z2
(it)
|
1990-04-13 |
1993-09-24 |
Stilolinea Srl |
Penna a sfera del tipo a punta scrivente rientrante
|
WO1991016929A1
(fr)
|
1990-05-10 |
1991-11-14 |
Novo Nordisk A/S |
PREPARATION PHARMACEUTIQUE CONTENANT DES n-GLYCOFUROLS ET DES n-ETHYLENE GLYCOLS
|
US5257987A
(en)
|
1990-05-21 |
1993-11-02 |
Pharmetrix Corporation |
Controlled release osmotic infusion system
|
DK0549694T3
(da)
|
1990-09-21 |
1995-10-16 |
Novo Nordisk As |
Adaptertop
|
US5284480A
(en)
|
1990-11-09 |
1994-02-08 |
Medtronic, Inc. |
Inflation/deflation syringe with threaded plunger
|
GB9026191D0
(en)
|
1990-12-01 |
1991-01-16 |
Harris Pharma Ltd |
Breath actuated dispensing device
|
US5331954A
(en)
|
1990-12-21 |
1994-07-26 |
Novo Nordisk A/S |
Device for nasal delivery of liquid medications
|
US5232706A
(en)
|
1990-12-31 |
1993-08-03 |
Esteve Quimica, S.A. |
Oral pharmaceutical preparation containing omeprazol
|
AU641206B2
(en)
|
1991-01-22 |
1993-09-16 |
Eli Lilly And Company |
Multiple dose injection pen
|
DE69203472T2
(de)
|
1991-02-07 |
1996-01-04 |
Terumo Corp |
Dosiereinrichtung für Injektor.
|
US5272135A
(en)
|
1991-03-01 |
1993-12-21 |
Chiron Ophthalmics, Inc. |
Method for the stabilization of methionine-containing polypeptides
|
HU222249B1
(hu)
|
1991-03-08 |
2003-05-28 |
Amylin Pharmaceuticals Inc. |
Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
ES2119812T3
(es)
|
1991-03-27 |
1998-10-16 |
Novo Nordisk As |
Catalasa, su produccion y uso.
|
US5258377A
(en)
|
1991-04-08 |
1993-11-02 |
Taiho Pharmaceutical Co., Ltd. |
2-spirocyclopropyl 4-acylcephems
|
DE4112259A1
(de)
|
1991-04-15 |
1992-10-22 |
Medico Dev Investment Co |
Injektionsgeraet
|
DK68991D0
(da)
|
1991-04-17 |
1991-04-17 |
Novo Nordisk As |
Manifold
|
US5645052A
(en)
|
1991-04-26 |
1997-07-08 |
The Boc Group Plc |
Anaesthetic vaporizer with expandable/contractable reservoir for pumping liquid anaesthetic
|
SE9101381D0
(sv)
|
1991-05-07 |
1991-05-07 |
Tomas Moks |
Peptide hormone solution
|
DK0525525T3
(da)
|
1991-07-24 |
1995-10-02 |
Medico Dev Investment Co |
Injektor
|
DK175491D0
(da)
|
1991-10-18 |
1991-10-18 |
Novo Nordisk As |
Apparat
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
DE69214835T2
(de)
|
1991-11-29 |
1997-04-03 |
Novo Nordisk As |
Stiftförmige spritze
|
DK194291D0
(da)
|
1991-11-29 |
1991-11-29 |
Novo Nordisk As |
Sproejte til automatisk injektion.
|
US5246417A
(en)
|
1991-12-11 |
1993-09-21 |
Alza Corporation |
Indicator for iontophoresis system
|
US5849700A
(en)
|
1991-12-20 |
1998-12-15 |
Novo Nordisk A/S |
Pharmaceutical formulation
|
FR2686460B1
(fr)
|
1992-01-20 |
1994-03-11 |
Labinal Precision Mecanique |
Organe de contact electrique femelle.
|
US5279586A
(en)
|
1992-02-04 |
1994-01-18 |
Becton, Dickinson And Company |
Reusable medication delivery pen
|
CH682968B5
(fr)
|
1992-02-12 |
1994-06-30 |
Rolex Montres |
Procédé de fabrication d'un joint et joint pour dispositif de commande étanche pour montre obtenu selon ce procédé.
|
CH682806A5
(de)
|
1992-02-21 |
1993-11-30 |
Medimpex Ets |
Injektionsgerät.
|
DE4208677A1
(de)
|
1992-03-18 |
1993-09-23 |
Injecta Gmbh Steinach |
Injektionsvorrichtung, insbesondere fuer sehgeschaedigte diabetiker
|
DK36492D0
(da)
|
1992-03-19 |
1992-03-19 |
Novo Nordisk As |
Praeparat
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
WO1993018812A1
(fr)
|
1992-03-25 |
1993-09-30 |
Tebro S.A. |
Distributeur a jet de poudre pour traitements par inhalation de medicament
|
US5271527A
(en)
|
1992-04-02 |
1993-12-21 |
Habley Medical Technology Corporation |
Reusable pharmaceutical dispenser with full stroke indicator
|
US5281198A
(en)
|
1992-05-04 |
1994-01-25 |
Habley Medical Technology Corporation |
Pharmaceutical component-mixing delivery assembly
|
JP3631490B2
(ja)
|
1992-05-13 |
2005-03-23 |
ノバルティス ファーマ株式会社 |
シクロスポリン含有眼科用組成物
|
BR9306551A
(pt)
|
1992-06-15 |
1998-09-15 |
Pfizer |
Derivados de peptídeo do tipo glucagona e de insulinotropina
|
UA26190C2
(uk)
|
1992-07-28 |
1999-07-19 |
Сейфтек Ай Лімітед |
Шприц
|
GB9219849D0
(en)
|
1992-09-19 |
1992-10-28 |
Hypoguard Uk Ltd |
Device
|
EP0649316B2
(fr)
|
1992-10-15 |
2013-08-28 |
The General Hospital Corporation |
Pompe a perfusion comportant une bibliotheque electronique de medicaments chargeable
|
US5545147A
(en)
|
1992-10-20 |
1996-08-13 |
Eli Lilly And Company |
Anti-backup improvement for hypodermic syringes
|
US5378233A
(en)
|
1992-11-18 |
1995-01-03 |
Habley Medical Technology Corporation |
Selected dose pharmaceutical dispenser
|
US5320609A
(en)
|
1992-12-07 |
1994-06-14 |
Habley Medical Technology Corporation |
Automatic pharmaceutical dispensing syringe
|
GB9226423D0
(en)
|
1992-12-18 |
1993-02-10 |
Sams Bernard |
Incrementing mechanisms
|
CA2156492A1
(fr)
|
1993-02-19 |
1994-09-01 |
Gabriel Meyer |
Seringue preremplie pour stockage et transfert d'une substance medicamenteuse liquide et sterile
|
US5383865A
(en)
|
1993-03-15 |
1995-01-24 |
Eli Lilly And Company |
Medication dispensing device
|
ZA941881B
(en)
|
1993-04-02 |
1995-09-18 |
Lilly Co Eli |
Manifold medication injection apparatus and method
|
US5584815A
(en)
|
1993-04-02 |
1996-12-17 |
Eli Lilly And Company |
Multi-cartridge medication injection device
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
SE9301494D0
(sv)
|
1993-04-30 |
1993-04-30 |
Kabi Pharmacia Ab |
A device for dosing liquid preparation
|
DK52393D0
(fr)
|
1993-05-05 |
1993-05-05 |
Novo Nordisk As |
|
WO1995005848A1
(fr)
|
1993-08-24 |
1995-03-02 |
Novo Nordisk A/S |
Peptide-1 du type glucagon a action prolongee
|
WO1995007931A1
(fr)
|
1993-09-17 |
1995-03-23 |
Novo Nordisk A/S |
Insuline acylee
|
GB9320782D0
(en)
|
1993-10-08 |
1993-12-01 |
Univ Leeds Innovations Ltd |
Stabilising of proteins on solution
|
ATE188611T1
(de)
|
1993-11-19 |
2000-01-15 |
Searle & Co |
Transdermale zusammensetzung von n-(n-(5-(4- (aminoiminomethyl)phenyl-1-oxopentyl)-l-alpha- aspartyl)-l-phenylalanin oder deren esterderivaten und ihre pharmazeutischverwendbaren salze
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
US5478316A
(en)
|
1994-02-02 |
1995-12-26 |
Becton, Dickinson And Company |
Automatic self-injection device
|
US5562623A
(en)
|
1994-02-14 |
1996-10-08 |
Univec |
Single-use syringe assembly including spring clip lock and plunger
|
US5514097A
(en)
|
1994-02-14 |
1996-05-07 |
Genentech, Inc. |
Self administered injection pen apparatus and method
|
AU1847695A
(en)
|
1994-02-22 |
1995-09-04 |
Syntex-Synergen Neuroscience Joint Venture, The |
Pharmaceutical formulations of cntf
|
WO1995029996A1
(fr)
|
1994-05-03 |
1995-11-09 |
Novo Nordisk A/S |
Glucose-oxydase alcaline
|
GB9409496D0
(en)
|
1994-05-12 |
1994-06-29 |
London Health Ass |
Method for improving glycaemic control in diabetes
|
US5750140A
(en)
|
1994-05-20 |
1998-05-12 |
Novo Nordisk A/S |
Transdermal delivery of tiagabine
|
US5652216A
(en)
|
1994-05-26 |
1997-07-29 |
Novo Nordisk A/S |
Pharmaceutical preparation
|
CA2197671A1
(fr)
|
1994-06-15 |
1995-12-21 |
Hubert Menendez |
Dispositif de blocage pour seringue ou intrument du genre
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5827232A
(en)
|
1994-06-22 |
1998-10-27 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
US5725508A
(en)
|
1994-06-22 |
1998-03-10 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
US5440976A
(en)
|
1994-08-23 |
1995-08-15 |
Fred Giuliano |
Adjustable dispensing stirrer for soluble sweeteners
|
US5823998A
(en)
|
1994-08-24 |
1998-10-20 |
Eli Lilly Japan Kabushiki Kaisha |
Injection apparatus
|
US5549574A
(en)
|
1994-08-30 |
1996-08-27 |
Eli Lilly And Company |
Cartridge assembly for use in a pen-type medicament injector
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
CA2157219C
(fr)
|
1994-08-31 |
2010-10-05 |
Munehiro Noda |
Procede pour la purification d'albumine de serum humain recombinante
|
EP0779780A1
(fr)
|
1994-09-09 |
1997-06-25 |
Novo Nordisk A/S |
Nettoyage, desinfection et conservation des lentilles de contact
|
US5549575A
(en)
|
1994-09-13 |
1996-08-27 |
Becton Dickinson And Company |
Cartridge retainer assembly for medication delivery pen
|
US5582598A
(en)
|
1994-09-19 |
1996-12-10 |
Becton Dickinson And Company |
Medication delivery pen with variable increment dose scale
|
US5882718A
(en)
|
1994-09-20 |
1999-03-16 |
Novo Nordisk A/S |
Method for treating an aqueous protein solution to kill microorganisms therein without causing coagulation and composition thereof
|
ZA958073B
(en)
|
1994-09-28 |
1996-04-23 |
Anthony William Manicom |
Method of and apparatus for administering a drug to a patient
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
EP0796106B1
(fr)
|
1994-12-23 |
2003-03-19 |
Novo Nordisk A/S |
Compositions a base de glp-1 et a action prolongee
|
CA2211316C
(fr)
|
1995-02-03 |
2013-10-01 |
Novo Nordisk A/S |
Technique de mise au point de mutants d'amylase-alpha dotes de proprietes predefinies
|
AU695129B2
(en)
|
1995-02-06 |
1998-08-06 |
Genetics Institute, Llc |
Formulations for IL-12
|
GB9503969D0
(en)
|
1995-02-28 |
1995-04-19 |
Sams Bernard |
Incrementing mechanism
|
NZ302558A
(en)
|
1995-03-07 |
1999-11-29 |
Lilly Co Eli |
Dispensing apparatus with a medication cartridge with a manually adjustable metering mechanism
|
AU720966B2
(en)
|
1995-03-17 |
2000-06-22 |
Novo Nordisk A/S |
Insulin derivatives
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
EP0828753B1
(fr)
|
1995-06-02 |
2003-03-26 |
Novozymes A/S |
Traitement d'une solution proteique avec un compose d'al/fe, suivi d'une concentration membranaire
|
KR100427750B1
(ko)
|
1995-06-02 |
2004-08-02 |
노보 노르디스크 에이/에스 |
피스톤로드의자동회수
|
US5631347A
(en)
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
DE69621131T2
(de)
|
1995-06-13 |
2002-11-28 |
Novozymes As |
4-substituierte-phenylboronsäuren als enzymstabilisatoren
|
US5674204A
(en)
|
1995-09-19 |
1997-10-07 |
Becton Dickinson And Company |
Medication delivery pen cap actuated dose delivery clutch
|
US5688251A
(en)
|
1995-09-19 |
1997-11-18 |
Becton Dickinson And Company |
Cartridge loading and priming mechanism for a pen injector
|
JP3060287B2
(ja)
|
1995-10-09 |
2000-07-10 |
参天製薬株式会社 |
アパファントを主薬とする水性点眼剤
|
US5899879A
(en)
|
1995-12-19 |
1999-05-04 |
Genesis Medical Technologies, Inc. |
Spring-actuated needleless injector
|
EP0959922B1
(fr)
|
1996-02-23 |
2003-05-21 |
Novo Nordisk A/S |
Seringue avec une representation electronique des parametres
|
JP4225570B2
(ja)
|
1996-03-05 |
2009-02-18 |
ロベール・ガーニー |
緩衝化されたオルトエステルポリマーを含有する医薬組成物
|
ATE494027T1
(de)
|
1996-03-12 |
2011-01-15 |
Novo Nordisk As |
Injektionsvorrichtung mit elektronischer anzeige der gewählten dosis
|
JP3741730B2
(ja)
|
1996-04-02 |
2006-02-01 |
テクファーマ・ライセンシング・アクチェンゲゼルシャフト |
注射装置
|
BR9708857A
(pt)
|
1996-04-24 |
1999-08-03 |
Novo Nordisk As |
Agulha de injeção
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
CZ433898A3
(cs)
|
1996-07-03 |
1999-04-14 |
Alza Corporation |
Nevodné protické peptidové formulace
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
IL127586A0
(en)
|
1996-07-05 |
1999-10-28 |
Novo Nordisk As |
Dose setting device
|
DE69724784T2
(de)
|
1996-07-05 |
2004-07-15 |
Novo Nordisk A/S |
Vorrichtung zur automatischen einführung einer nadel
|
HUP9904152A3
(en)
|
1996-07-05 |
2000-05-29 |
Novo Nordisk As |
Flexible piston rod
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
US5962407A
(en)
|
1996-07-26 |
1999-10-05 |
Kelly; Michael T. |
Loloatin derivatives and analogs
|
AU4063697A
(en)
|
1996-08-08 |
1998-02-25 |
Amylin Pharmaceuticals, Inc. |
Methods for regulating gastrointestinal motility
|
JPH10101696A
(ja)
|
1996-08-08 |
1998-04-21 |
Shinotesuto:Kk |
形質転換体にて発現される蛋白質に含まれる夾雑物質の除去方法及び精製蛋白質
|
US5709662A
(en)
|
1996-08-23 |
1998-01-20 |
Becton Dickinson France, S.A. |
Cartridge for an injection device
|
US5843036A
(en)
|
1996-08-23 |
1998-12-01 |
Becton Dickinson And Company |
Non-dosing cartridge for an injection device
|
CA2468374C
(fr)
|
1996-08-30 |
2010-12-21 |
Novo-Nordisk A/S |
Derives de glp-1
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6277819B1
(en)
|
1996-08-30 |
2001-08-21 |
Eli Lilly And Company |
Use of GLP-1 or analogs in treatment of myocardial infarction
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6384016B1
(en)
|
1998-03-13 |
2002-05-07 |
Novo Nordisk A/S |
Stabilized aqueous peptide solutions
|
US6379339B1
(en)
|
1996-09-13 |
2002-04-30 |
Nova Nordisk A/S |
Syringe
|
US5947934A
(en)
|
1996-09-13 |
1999-09-07 |
Novo Nordisk A/S |
Dose display for an injection syringe
|
RU2190430C2
(ru)
|
1996-09-13 |
2002-10-10 |
Ново Нордиск А/С |
Шприц для инъекций с часовым циферблатом
|
US6110149A
(en)
|
1996-09-13 |
2000-08-29 |
Novo Nordisk A/S |
Syringe
|
ATE209935T1
(de)
|
1996-09-20 |
2001-12-15 |
Novo Nordisk As |
Arbeitszylinder
|
US6146361A
(en)
|
1996-09-26 |
2000-11-14 |
Becton Dickinson And Company |
Medication delivery pen having a 31 gauge needle
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
TW524667B
(en)
|
1996-12-05 |
2003-03-21 |
Pfizer |
Parasiticidal pyrazoles
|
US5954689A
(en)
|
1996-12-20 |
1999-09-21 |
Novo Nordisk A/S |
Jet injector
|
JP4798814B2
(ja)
|
1997-01-07 |
2011-10-19 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
食物摂取低減用のエキセンジンおよびそのアゴニストの使用
|
US7312196B2
(en)
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
US6136784A
(en)
|
1997-01-08 |
2000-10-24 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
TW503113B
(en)
|
1997-01-16 |
2002-09-21 |
Senju Pharma Co |
Aqueous suspension for nasal administration
|
RU2180218C2
(ru)
|
1997-01-20 |
2002-03-10 |
Джапэн Энерджи Корпорейшн |
Способ стабилизации гирудина и/или вариантов гирудина, лиофилизированная фармацевтическая композиция, полученная с применением данного способа
|
GB2321419B
(en)
|
1997-01-27 |
2001-02-07 |
Medic Aid Ltd |
Atomizer
|
JP2001511033A
(ja)
|
1997-02-04 |
2001-08-07 |
ノボ ノルディスク アクティーゼルスカブ |
液状薬剤懸濁液の投与装置
|
DE29703820U1
(de)
|
1997-03-03 |
1998-07-02 |
Medico Dev Investment Co |
Injektionsgerät
|
US5898028A
(en)
|
1997-03-20 |
1999-04-27 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
US20010020155A1
(en)
|
1997-03-25 |
2001-09-06 |
Soren Mikkelsen |
Injection system
|
WO1998043658A1
(fr)
|
1997-03-31 |
1998-10-08 |
Eli Lilly And Company |
Analogues de peptide 1 assimile au glucagon (glp-1)
|
CA2236519C
(fr)
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methodes pour ameliorer le fonctionnement du gros intestin
|
US7101853B2
(en)
|
1997-05-06 |
2006-09-05 |
Amylin Pharmaceuticals, Inc. |
Method for treating or preventing gastritis using amylin or amylin agonists
|
RU2111019C1
(ru)
|
1997-05-22 |
1998-05-20 |
Сергей Александрович Хворостов |
Универсальный инъектор
|
ATE277948T1
(de)
|
1997-05-23 |
2004-10-15 |
Predrag Sikiric |
Bpc peptid salze mit organ-schützender aktivität, deren herstellung und therapeutische verwendung
|
US7910548B2
(en)
|
1997-06-06 |
2011-03-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity
|
WO1998056381A1
(fr)
|
1997-06-09 |
1998-12-17 |
Bridge Pharma, Inc. |
Composes a combinaison d'activites antihistaminique et stabilisatrice des membranes cellulaires de mastocytes, utilises a des fins ophtalmiques
|
US6074372A
(en)
|
1997-06-09 |
2000-06-13 |
Novo Nordisk A/S |
Dose setting mechanism and an injection syringe having such a dose setting mechanism
|
US6003736A
(en)
|
1997-06-09 |
1999-12-21 |
Novo Nordisk A/S |
Device for controlled dispensing of a dose of a liquid contained in a cartridge
|
ZA984697B
(en)
|
1997-06-13 |
1999-12-01 |
Lilly Co Eli |
Stable insulin formulations.
|
US5961496A
(en)
|
1997-06-17 |
1999-10-05 |
Novo Nordisk A/S |
Syringe with tiltable nut for quick piston disengagement
|
US6796970B1
(en)
|
1997-06-17 |
2004-09-28 |
Novo Nordisk A/S |
Dose setting device
|
JP3503129B2
(ja)
|
1997-06-30 |
2004-03-02 |
荒川化学工業株式会社 |
カラーフィルタ層用剥離剤およびカラーフィルタ用ガラス基板の再生方法
|
WO1999002210A1
(fr)
|
1997-07-11 |
1999-01-21 |
Novo Nordisk A/S |
Dispositif d'enregistrement du reglage d'un dispositif medical
|
AU8333398A
(en)
|
1997-07-14 |
1999-02-10 |
Novo Nordisk A/S |
Injection member
|
WO1999003520A1
(fr)
|
1997-07-14 |
1999-01-28 |
Novo Nordisk A/S |
Ampoule cylindrique
|
DE19730999C1
(de)
|
1997-07-18 |
1998-12-10 |
Disetronic Licensing Ag |
Dosierknopfsicherung an einer Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
|
US5957896A
(en)
|
1997-08-11 |
1999-09-28 |
Becton, Dickinson And Company |
Medication delivery pen
|
FR2767479B1
(fr)
|
1997-08-22 |
1999-10-22 |
Aguettant Lab |
Dispositif d'injection de medicament
|
AU9202398A
(en)
|
1997-09-29 |
1999-04-23 |
Becton Dickinson & Company |
Injection device and drug cartridge for preventing cross-use of the device and drug cartridge
|
WO1999016417A1
(fr)
|
1997-10-01 |
1999-04-08 |
Flemington Pharmaceutical Corporation |
Pulverisation ou capsule buccale, polaire et non polaire
|
CN1240718C
(zh)
|
1997-10-24 |
2006-02-08 |
诺沃挪第克公司 |
人胰岛素衍生物的聚集体
|
JP4239131B2
(ja)
|
1997-10-24 |
2009-03-18 |
ジェネンテック・インコーポレーテッド |
分子の精製
|
US6312413B1
(en)
|
1997-10-30 |
2001-11-06 |
Novo Nordisk A/S |
Cylinder ampoule
|
JP2001525371A
(ja)
|
1997-12-05 |
2001-12-11 |
イーライ・リリー・アンド・カンパニー |
Glp−1製剤
|
ZA9811127B
(en)
|
1997-12-09 |
2000-07-11 |
Lilly Co Eli |
Stabilized teriparatide solutions.
|
DE29721752U1
(de)
|
1997-12-09 |
1998-02-12 |
Siemens Ag |
Crimpkontakt für Stecksysteme
|
US6380357B2
(en)
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
JPH11249087A
(ja)
|
1997-12-18 |
1999-09-17 |
Tome:Kk |
コンタクトレンズ用液剤
|
WO1999034764A2
(fr)
|
1998-01-09 |
1999-07-15 |
Amylin Pharmaceuticals, Inc. |
Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline
|
WO1999034822A1
(fr)
|
1998-01-09 |
1999-07-15 |
Amylin Pharmaceuticals, Inc. |
Formulations de peptides agonistes d'amyline
|
ES2153711T3
(es)
|
1998-01-30 |
2001-03-01 |
Novo Nordisk As |
Jeringuilla de inyeccion.
|
CA2284847A1
(fr)
|
1998-01-30 |
1999-08-05 |
Suntory Limited |
Procede de production de peptides au moyen d'un peptide auxiliaire
|
DE69943039D1
(de)
|
1998-02-13 |
2011-01-27 |
Amylin Pharmaceuticals Inc |
Neue verbindungen mit gemischter amylin aktivität
|
WO1999040788A1
(fr)
|
1998-02-13 |
1999-08-19 |
Amylin Pharmaceuticals, Inc. |
Effets inotropiques et diuretiques de l'extendine et du gpl-1
|
WO1999040966A1
(fr)
|
1998-02-13 |
1999-08-19 |
Graham Francois Duirs |
Dispositif servant a administrer un medicament
|
US6096010A
(en)
|
1998-02-20 |
2000-08-01 |
Becton, Dickinson And Company |
Repeat-dose medication delivery pen
|
US6221053B1
(en)
|
1998-02-20 |
2001-04-24 |
Becton, Dickinson And Company |
Multi-featured medication delivery pen
|
US6248095B1
(en)
|
1998-02-23 |
2001-06-19 |
Becton, Dickinson And Company |
Low-cost medication delivery pen
|
AU2610799A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Glp-1 derivatives with helix-content exceeding 25 per cent, forming partially structured micellar-like aggregates
|
EP1056774A1
(fr)
|
1998-02-27 |
2000-12-06 |
Novo Nordisk A/S |
Derives de glp-1 tronques a l'extremite n-terminale
|
EP1056775B1
(fr)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
Derives de gpl-1 et de l'extendine au profil d'action etendu
|
AU2610699A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Derivatives of glp-1 analogs
|
EP1062240B1
(fr)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
Derives de glp-1 modifies a l'extremite n-terminale
|
AU2612599A
(en)
|
1998-03-13 |
1999-10-11 |
Novo Nordisk A/S |
Stabilized aqueous peptide solutions
|
US6245572B1
(en)
|
1998-05-01 |
2001-06-12 |
University Of Tennessee Research Corporation |
Flow cytometric characterization of amyloid fibrils
|
US6281225B1
(en)
|
1998-06-11 |
2001-08-28 |
Cerus Corporation |
Inhibiting proliferation of arterial smooth muscle cells
|
EP1094857B1
(fr)
|
1998-07-08 |
2003-10-08 |
Novo Nordisk A/S |
Dispositif medical d'administration et ensemble cartouche destine a etre utilise avec celui-ci
|
JP2002524514A
(ja)
|
1998-09-17 |
2002-08-06 |
イーライ・リリー・アンド・カンパニー |
タンパク質製剤
|
US6033376A
(en)
|
1998-09-30 |
2000-03-07 |
Allergan Sales, Inc. |
Wound shaper sleeve
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
US6605067B1
(en)
|
1998-11-20 |
2003-08-12 |
Novo Nordisk A/S |
Injection needle
|
US6375975B1
(en)
|
1998-12-21 |
2002-04-23 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary application
|
WO2000037098A1
(fr)
|
1998-12-22 |
2000-06-29 |
Eli Lilly And Company |
Formulation de longue conservation de peptide-1 de type glucagon
|
DE29900482U1
(de)
|
1999-01-14 |
2000-08-31 |
Medico Dev Investment Co |
Injektionsgerät
|
CN100356978C
(zh)
|
1999-01-14 |
2007-12-26 |
安米林药品公司 |
新型exendin激动剂制剂及其给药方法
|
WO2000047332A1
(fr)
|
1999-02-14 |
2000-08-17 |
Ing. Erich Pfeiffer Gmbh |
Distributeur pour milieux coulants
|
US6258062B1
(en)
|
1999-02-25 |
2001-07-10 |
Joseph M. Thielen |
Enclosed container power supply for a needleless injector
|
US6444788B1
(en)
|
1999-03-15 |
2002-09-03 |
Novo Nordisk A/S |
Ion exchange chromatography of GLP-1, analogs and derivatives thereof
|
AU3273500A
(en)
|
1999-03-17 |
2000-10-04 |
Novo Nordisk A/S |
Method for acylating peptides and novel acylating agents
|
SE9901366D0
(sv)
|
1999-04-16 |
1999-04-16 |
Pharmacia & Upjohn Ab |
Injector device and method for its operation
|
FR2793684B1
(fr)
|
1999-05-17 |
2001-08-10 |
Ethypharm Lab Prod Ethiques |
Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
WO2001001774A1
(fr)
|
1999-06-17 |
2001-01-11 |
Regents Of The University Of California |
Preservation d'organes par perfusion cardiaque continue avec du peg-hb en vue d'une conservation amelioree en hypothermie
|
EP1133312B8
(fr)
|
1999-06-21 |
2007-10-17 |
Eli Lilly And Company |
Utilisation combinee de thiazolidinediones et de peptide-1 de type glucagone et d'agonistes de ces derniers pour traiter diabetes non insulino-dependant.
|
WO2001000223A2
(fr)
|
1999-06-25 |
2001-01-04 |
Minimed Inc. |
Therapie anti diabete a agents multiples
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
EP1076066A1
(fr)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides abaissant le taux de glucose sanguin
|
ES2258469T3
(es)
|
1999-08-05 |
2006-09-01 |
Becton Dickinson And Company |
Lapiz de administracion de medicacion.
|
TW453884B
(en)
|
1999-09-16 |
2001-09-11 |
Novo Nordisk As |
Dose setting limiter
|
AU7363000A
(en)
|
1999-09-20 |
2001-04-24 |
Eli Lilly And Company |
Method for reducing the risk of cancer
|
US6514230B1
(en)
|
1999-10-12 |
2003-02-04 |
Novo Nordisk A/S |
Air shot mechanism for electronic injection devices
|
US6569832B1
(en)
|
1999-11-12 |
2003-05-27 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
EA004631B1
(ru)
|
1999-12-16 |
2004-06-24 |
Эли Лилли Энд Компани |
Полипептидные композиции, обладающие повышенной стабильностью
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
GB9930882D0
(en)
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
JP2003519664A
(ja)
|
2000-01-11 |
2003-06-24 |
ノボ ノルディスク アクティーゼルスカブ |
Glp−1誘導体の経上皮送達
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
EP1396499A3
(fr)
|
2000-01-27 |
2004-12-29 |
Eli Lilly And Company |
Procédé de solubilisation de composés 1-peptidiques de type glucagon (GLP-1)
|
KR20020073184A
(ko)
|
2000-01-27 |
2002-09-19 |
일라이 릴리 앤드 캄파니 |
글루카곤 유사 펩티드 1 화합물을 용해시키는 방법
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
GB0007071D0
(en)
|
2000-03-24 |
2000-05-17 |
Sams Bernard |
One-way clutch mechanisms and injector devices
|
WO2001077141A1
(fr)
|
2000-04-06 |
2001-10-18 |
Novo Nordisk A/S |
Traitement de polypeptides par choc thermique chaud
|
US6692472B2
(en)
|
2000-05-04 |
2004-02-17 |
Novo Nordisk A/S |
Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device
|
CA2380423A1
(fr)
|
2000-05-17 |
2001-11-22 |
Bionebraska, Inc. |
Preparations pharmaceutiques peptidiques
|
US6716198B2
(en)
|
2000-05-18 |
2004-04-06 |
Novo Nordisk A/S |
Injection device
|
US6547763B2
(en)
|
2000-05-18 |
2003-04-15 |
Novo Nordisk A/S |
Dose display for injection device
|
US6547764B2
(en)
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
ATE424413T1
(de)
|
2000-06-16 |
2009-03-15 |
Lilly Co Eli |
Analoge des glucagon-ähnlichen peptids-1
|
US6663602B2
(en)
|
2000-06-16 |
2003-12-16 |
Novo Nordisk A/S |
Injection device
|
US6369419B1
(en)
|
2000-06-23 |
2002-04-09 |
International Business Machines Corporation |
Self-aligned near surface strap for high density trench DRAMS
|
JP2004503337A
(ja)
|
2000-07-14 |
2004-02-05 |
ノボ ノルディスク アクティーゼルスカブ |
液体薬物射出装置及び所望の投与量を射出させる方法
|
WO2002024257A1
(fr)
|
2000-09-22 |
2002-03-28 |
Novo Nordisk A/S |
Dispositif pour l'apport d'un medicament
|
JP4798833B2
(ja)
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
加熱処理工程を含むヒト血清アルブミンの製造方法
|
CZ308214B6
(cs)
|
2000-12-07 |
2020-03-04 |
Eli Lilly And Company |
GLP-1 fúzní proteiny
|
JP2004521093A
(ja)
|
2000-12-13 |
2004-07-15 |
イーライ・リリー・アンド・カンパニー |
グルカゴン様インスリン刺激性ペプチドを用いる長期治療計画
|
AU2002228608A1
(en)
|
2000-12-13 |
2002-06-24 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
US20020151467A1
(en)
|
2000-12-21 |
2002-10-17 |
Leung Frank K. |
Methods and compositions for oral insulin delivery
|
US6899699B2
(en)
|
2001-01-05 |
2005-05-31 |
Novo Nordisk A/S |
Automatic injection device with reset feature
|
GB2371227A
(en)
|
2001-01-10 |
2002-07-24 |
Grandis Biotech Gmbh |
Crystallisation - resistant aqueous growth hormone formulations
|
EP1361908B1
(fr)
|
2001-02-14 |
2007-12-19 |
Novo Nordisk A/S |
Dispositif d'injection ou d'injection commande electroniquement
|
AU2002233089B2
(en)
|
2001-02-16 |
2005-12-22 |
Conjuchem Biotechnologies Inc. |
Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
|
EP1949908A1
(fr)
|
2001-03-07 |
2008-07-30 |
Novo Nordisk A/S |
Utilisation combinée de dérivés d'analogues GLP-1 et ligands PPAR
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
ES2400055T3
(es)
|
2001-05-16 |
2013-04-05 |
Eli Lilly And Company |
Aparato inyector de medicamentos
|
EP1391209A4
(fr)
|
2001-05-30 |
2009-12-16 |
Chugai Pharmaceutical Co Ltd |
Formulations de proteines
|
GB0113881D0
(en)
|
2001-06-07 |
2001-08-01 |
Innovate Biomed Ltd |
Foil cutting system
|
EP1412384B1
(fr)
|
2001-06-28 |
2007-12-26 |
Novo Nordisk A/S |
Formulation stable de glp-1 modifie
|
US6872705B2
(en)
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
DE10163326A1
(de)
|
2001-07-30 |
2003-02-27 |
Disetronic Licensing Ag |
Verabreichungsgerät mit Dosiervorrichtung
|
CN1335182A
(zh)
|
2001-08-08 |
2002-02-13 |
华中科技大学 |
胰岛素口腔喷剂及其制备工艺
|
WO2003020201A2
(fr)
|
2001-08-28 |
2003-03-13 |
Eli Lilly And Company |
Pre-melanges de polypeptide glp-1 et d'insuline basale
|
US6676641B2
(en)
|
2001-09-05 |
2004-01-13 |
Futura Medical Technologies, Inc. |
Retractable hypodermic syringe
|
IL160917A0
(en)
|
2001-10-18 |
2004-08-31 |
Bristol Myers Squibb Co |
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
|
MXPA04003569A
(es)
|
2001-10-19 |
2004-07-23 |
Lilly Co Eli |
Mezclas bifasicas de glp-1 e insulina.
|
ES2614603T3
(es)
|
2002-02-20 |
2017-06-01 |
Emisphere Technologies, Inc. |
Procedimiento de administración de moléculas GLP-1
|
WO2003074029A1
(fr)
|
2002-03-07 |
2003-09-12 |
Vectura Limited |
Formulations a base de particules multiples a fusion rapide pour administration orale
|
AU2003215524A1
(en)
|
2002-03-15 |
2003-09-29 |
Natimmune A/S |
Pharmaceutical compositions comprising mannose binding lectin
|
JP2005535569A
(ja)
|
2002-04-04 |
2005-11-24 |
ノボ・ノルデイスク・エー/エス |
Glp−1アゴニスト及び心臓血管合併症
|
CA2491478A1
(fr)
|
2002-07-09 |
2004-01-15 |
Sandoz Ag |
Formulations liquides a haute concentration en hormone de croissance humaine (hch) comprenant du phenol
|
US6945961B2
(en)
|
2002-07-10 |
2005-09-20 |
Novo Nordisk A/S |
Injection device
|
EP1521607A1
(fr)
|
2002-07-10 |
2005-04-13 |
Novo Nordisk A/S |
Dispositif d'injection a limiteur de dosage
|
EP1391794A1
(fr)
|
2002-07-23 |
2004-02-25 |
Novo Nordisk A/S |
Dispositif muni d'indicateur de temps
|
EP1539279B1
(fr)
|
2002-08-29 |
2006-06-28 |
Novo Nordisk A/S |
Dispositif d'injection se chargeant par l'avant
|
ES2327731T3
(es)
|
2002-09-24 |
2009-11-03 |
Shl Group Ab |
Dispositivo de inyeccion.
|
EP1546187B1
(fr)
|
2002-09-25 |
2008-06-04 |
Novo Nordisk A/S |
Procede de purification comprenant une microfiltration a des temperatures elevees
|
US7273921B2
(en)
|
2002-09-25 |
2007-09-25 |
Novo Nordisk A/S |
Method for producing acylated peptides
|
WO2004037168A2
(fr)
|
2002-10-18 |
2004-05-06 |
Amylin Pharmaceuticals, Inc. |
Traitement de la pancreatite avec de l'amyline
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
JP2006514035A
(ja)
|
2002-12-17 |
2006-04-27 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
心不整脈の予防および治療
|
WO2004066939A2
(fr)
|
2003-01-27 |
2004-08-12 |
Sarnoff Corporation |
Systeme d'administration de medicament a liberation controlee
|
GB0304822D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0304823D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0304824D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0306642D0
(en)
|
2003-03-22 |
2003-04-30 |
Dca Design Int Ltd |
Improvements in and relating to an injector for a medical product
|
GB0308267D0
(en)
|
2003-04-10 |
2003-05-14 |
Dca Design Int Ltd |
Improvements in and relating to a pen-type injector
|
WO2004089985A1
(fr)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Compositions pharmaceutiques stables
|
US8008255B2
(en)
|
2003-05-30 |
2011-08-30 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
CN1812807A
(zh)
*
|
2003-06-03 |
2006-08-02 |
诺沃挪第克公司 |
稳定化的药物肽组合物
|
KR101293507B1
(ko)
|
2003-06-03 |
2013-08-06 |
노보 노르디스크 에이/에스 |
안정화된 약학적 펩티드 조성물
|
EP2292254A3
(fr)
|
2003-06-03 |
2011-12-14 |
Novo Nordisk A/S |
Compositions pharmaceutiques stabilisées de peptide
|
EP1656170B1
(fr)
|
2003-08-12 |
2019-03-13 |
Eli Lilly And Company |
Appareil de distribution de medicaments a triple filetage presentant un avantage mecanique
|
US20070275877A1
(en)
|
2003-08-29 |
2007-11-29 |
Amylin Pharmaceuticals, Inc. |
Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
|
TW200526254A
(en)
|
2003-09-19 |
2005-08-16 |
Novo Nordisk As |
Novel GLP-1 derivatives
|
PE20050444A1
(es)
|
2003-10-31 |
2005-08-09 |
Takeda Pharmaceutical |
Compuestos de piridina como inhibidores de la peptidasa
|
ATE447412T1
(de)
|
2003-11-04 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Antagonist-anti-cd40-monoklonale antikörper und anwendungsverfahren
|
SG10201701737XA
(en)
|
2003-11-06 |
2017-04-27 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugation to ligands
|
US20060287221A1
(en)
|
2003-11-13 |
2006-12-21 |
Novo Nordisk A/S |
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
|
WO2005046716A1
(fr)
|
2003-11-13 |
2005-05-26 |
Novo Nordisk A/S |
Compositions pharmaceutiques solubles destinées à l'administration parentérale comprenant un peptide glp-1 et un peptide d'insuline à temps d'action de courte durée, utiles pour le traitement du diabète et de la boulimie
|
CA2545034C
(fr)
|
2003-11-20 |
2013-03-05 |
Novo Nordisk A/S |
Formulations peptidiques a base de propylene glycol optimales pour la production et l'utilisation dans des dispositifs d'injection
|
US7521527B2
(en)
|
2003-12-16 |
2009-04-21 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
GLP-1 pharmaceutical compositions
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
US20050143303A1
(en)
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
DE602005021858D1
(de)
|
2004-02-11 |
2010-07-29 |
Amylin Pharmaceuticals Inc |
Peptide der amylin familie, verfahren zu deren herstellung und verwendung
|
EP1765406A4
(fr)
|
2004-05-21 |
2012-11-28 |
Mediplex Corp |
Delivrance d'agents permettant d'ameliorer l'absorption mucosale d'agents therapeutiques
|
US7448385B2
(en)
|
2004-06-07 |
2008-11-11 |
Purepharm Inc. |
Nasal adaptation of an oral inhaler device
|
EP2316446A1
(fr)
|
2004-06-11 |
2011-05-04 |
Novo Nordisk A/S |
Remède contre l'obésité induite par les médicaments au moyen d'agonistes GLP-1
|
EP1906991A2
(fr)
|
2004-06-28 |
2008-04-09 |
Novo Nordisk A/S |
Methodes de traitement du diabete
|
EP2457580A1
(fr)
|
2004-08-25 |
2012-05-30 |
The UAB Research Foundation |
Activateurs de l'absorption pour l'administration de médicaments
|
EP2286837A3
(fr)
|
2004-11-01 |
2013-09-04 |
Amylin Pharmaceuticals, LLC |
Traitement de l'obésité et de maladies liés à l'obésité
|
CN101056650A
(zh)
|
2004-11-12 |
2007-10-17 |
诺和诺德公司 |
促胰岛素肽的稳定制剂
|
EP1814581B1
(fr)
|
2004-11-12 |
2016-03-16 |
Novo Nordisk A/S |
Preparations stables de peptides comprenant un analogue du glp-1 acyle et une insuline basale
|
EP2623095A1
(fr)
|
2004-11-16 |
2013-08-07 |
Elan Pharma International Limited |
Formulations injectables de nanoparticules d'olanzapine
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
AU2006207744B2
(en)
|
2005-01-21 |
2011-08-11 |
Novo Nordisk A/S |
An automatic injection device with a top release mechanism
|
AR062247A1
(es)
|
2005-03-08 |
2008-10-29 |
Pharmacia & Upjohn Co Llc |
Composiciones de anticuerpos anti-ctla-4
|
US8834891B2
(en)
|
2005-03-14 |
2014-09-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Immunogenic compositions comprising Lawsonia intracellularis
|
TWI372629B
(en)
*
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
WO2007014051A2
(fr)
|
2005-07-22 |
2007-02-01 |
Amylin Pharmaceuticals, Inc. |
Utilisation d'amyline et d'agonistes d'amyline comme agents cardioprotecteurs ou myoprotecteurs
|
WO2007022518A2
(fr)
|
2005-08-19 |
2007-02-22 |
Amylin Pharmaceuticals, Inc. |
Nouvelles utilisations de proteines glucoregulatoires
|
CA2633655A1
(fr)
|
2005-12-19 |
2007-07-05 |
Comentis, Inc. |
Preparations de mecamylamine topique pour administration oculaire et utilisations de celles-ci
|
DK3127551T3
(da)
|
2005-12-29 |
2020-10-12 |
Boehringer Ingelheim Animal Health Usa Inc |
Pcv2-immunogen-sammensætning til at mindske kliniske symptomer i grise
|
RU2419452C2
(ru)
|
2006-04-13 |
2011-05-27 |
Ипсен Фарма С.А.С. |
ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ hGLP-1, ЭКСЕНДИНА-4 И ИХ АНАЛОГОВ
|
AR061930A1
(es)
|
2006-07-18 |
2008-10-01 |
Centocor Inc |
Mimeticuerpos de glp-1 humanos, composiciones, metodos y usos
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
TW200843794A
(en)
|
2006-12-21 |
2008-11-16 |
Centocor Inc |
Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
|
GB0704846D0
(en)
|
2007-03-13 |
2007-04-18 |
Futura Medical Dev Ltd |
Topical pharmaceutical formulation
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
CN101842109B
(zh)
|
2007-09-05 |
2014-01-29 |
诺沃-诺迪斯克有限公司 |
用a-b-c-d-衍生的肽和它们的治疗用途
|
JP2010539037A
(ja)
|
2007-09-11 |
2010-12-16 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
治療剤としてのペプチドの使用
|
WO2009051992A1
(fr)
|
2007-10-19 |
2009-04-23 |
Bausch & Lomb Incorporated |
Compositions et procédés de traitement de maladies mettant en jeu une angiogenèse oculaire par inhibition d'une ou plusieurs tyrosine kinases de récepteurs sélectionnés
|
CA2705708A1
(fr)
|
2007-11-14 |
2009-05-22 |
Amylin Pharmaceuticals, Inc. |
Procedes de traitement de l'obesite et de maladies et de troubles associes a l'obesite
|
CA2708762A1
(fr)
|
2007-12-11 |
2009-06-18 |
Conjuchem Biotechnologies Inc. |
Formulation de conjugues de peptides insulinotropes
|
EP2340261B1
(fr)
|
2008-10-21 |
2017-12-20 |
Novo Nordisk A/S |
Dérivés d'amyline
|
WO2010107874A2
(fr)
|
2009-03-17 |
2010-09-23 |
Amylin Pharmaceuticals, Inc. |
Méthodes permettant d'agir sur la composition du corps au moyen d'agonistes d'amyline
|
EP2437816B1
(fr)
|
2009-06-04 |
2013-04-24 |
Novo Nordisk Health Care AG |
Dispositif de mélange avec un piston/inter-verrouillage de tige de piston
|
DK2459171T3
(en)
|
2009-07-31 |
2017-09-25 |
Sanofi Aventis Deutschland |
Long-acting insulin composition
|
KR20120089843A
(ko)
|
2009-07-31 |
2012-08-14 |
사노피-아벤티스 도이칠란트 게엠베하 |
인슐린 링커 접합체를 포함한 프로드럭
|
WO2011050008A2
(fr)
|
2009-10-19 |
2011-04-28 |
Amylin Pharmaceuticals, Inc. |
Polythérapie comprenant l'administration d'un amylinomimétique et d'un peptidomimétique de pyy pour obtenir une perte de poids et pour traiter l'obésité et les états pathologiques et les troubles métaboliques associés
|
EA022700B1
(ru)
|
2009-12-10 |
2016-02-29 |
Мерк Патент Гмбх |
Фармацевтическая композиция, содержащая олигопептиды
|
KR101817607B1
(ko)
|
2009-12-16 |
2018-01-11 |
노보 노르디스크 에이/에스 |
이중 아실화된 glp―1 유도체
|
WO2011104378A1
(fr)
|
2010-02-26 |
2011-09-01 |
Novo Nordisk A/S |
Peptides de traitement de l'obésité
|
WO2011109787A1
(fr)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Méthodes d'administration de peptides insulinotropes
|
WO2011109784A1
(fr)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Formulation de conjugués peptidiques insulinotropiques
|
BR112012024379A2
(pt)
|
2010-03-26 |
2017-01-10 |
Novo Nordisk As |
"peptídeos glucagon, seu uso, bem como composição farmacêutica"
|
KR20130101005A
(ko)
|
2010-07-28 |
2013-09-12 |
아밀린 파마슈티칼스, 엘엘씨. |
안정화된 영역을 갖는 glp-1 수용체 효능제 화합물
|
EP2438930A1
(fr)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Promédicaments comprenant un conjugué de liaison d'exendine
|
EP2637698B1
(fr)
|
2010-11-09 |
2022-04-20 |
Novo Nordisk A/S |
Dérivés de glp-1 doublement acylés
|
JP2014502984A
(ja)
|
2011-01-19 |
2014-02-06 |
ノヴォ ノルディスク アー/エス |
Glp−1組成物
|
WO2012104655A2
(fr)
|
2011-02-04 |
2012-08-09 |
Biocopea Limited |
Compositions et méthodes pour traiter l'inflammation chronique et les maladies inflammatoires
|
US20130035281A1
(en)
|
2011-02-09 |
2013-02-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
EP2696687B1
(fr)
|
2011-04-12 |
2016-10-26 |
Novo Nordisk A/S |
Dérivés glp-1 double-acylatés
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
RS59977B1
(sr)
|
2011-06-10 |
2020-03-31 |
Novo Nordisk As |
Polipeptidi
|
JP6040464B2
(ja)
|
2011-07-08 |
2016-12-07 |
アエゲリオン・ファーマシューティカルズ・インコーポレイテッドAegerion Pharmaceuticals, Inc. |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
US9132170B2
(en)
|
2011-07-29 |
2015-09-15 |
Case Western Reserve University |
Compositions and methods for treating cognitive deficits
|
US9758560B2
(en)
|
2011-09-06 |
2017-09-12 |
Novo Nordisk A/S |
GLP-1 derivatives
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
JP2015500823A
(ja)
|
2011-12-09 |
2015-01-08 |
ノヴォ ノルディスク アー/エス |
Glp−1アゴニスト
|
WO2013127779A1
(fr)
|
2012-03-01 |
2013-09-06 |
Novo Nordisk A/S |
Promédicaments à base de glp-1
|
CN102579350B
(zh)
|
2012-03-02 |
2013-04-24 |
海南灵康制药有限公司 |
右旋布洛芬脂质体固体制剂
|
AU2013243953A1
(en)
|
2012-04-02 |
2014-10-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9814761B2
(en)
|
2012-04-03 |
2017-11-14 |
Trustees Of Boston University |
Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
|
CN104395338B
(zh)
|
2012-04-19 |
2019-05-10 |
诺和诺德股份有限公司 |
人胰岛淀粉样多肽类似物
|
WO2013167455A1
(fr)
|
2012-05-08 |
2013-11-14 |
Novo Nordisk A/S |
Dérivés du glp-1 à double acylation
|
CN104519902B
(zh)
|
2012-05-08 |
2017-10-27 |
诺和诺德股份有限公司 |
双酰化glp‑1衍生物
|
WO2013177565A1
(fr)
|
2012-05-25 |
2013-11-28 |
Amylin Pharmaceuticals, Llc |
Compositions d'insuline/pramlintide et leurs procédés de fabrication et d'utilisation
|
WO2013190384A1
(fr)
|
2012-06-19 |
2013-12-27 |
Affinium Pharmaceuticals, Inc. |
Dérivés de type promédicament du (e)-n-méthyl-n-((3-méthylbenzofuran-2-yl) méthyl)-3-(7-oxo-5,6,7,8-tétrahydro-l,8-naphtyridin-3-yl)acrylamide
|
SI2866825T1
(sl)
|
2012-07-01 |
2020-07-31 |
Novo Nordisk A/S |
Uporaba dolgo delujočih peptidov GLP-1
|
US20150273069A1
(en)
*
|
2012-10-17 |
2015-10-01 |
Novo Nordisk A/S |
Fatty acid acylated amino acids for oral peptide delivery
|
RU2019116003A
(ru)
|
2013-03-15 |
2019-07-17 |
Ритм Фармасьютикалз, Инк. |
Фармацевтические композиции
|
KR102272671B1
(ko)
|
2013-05-02 |
2021-07-06 |
노보 노르디스크 에이/에스 |
Glp-1 화합물의 경구 투여
|
WO2014182950A1
(fr)
|
2013-05-10 |
2014-11-13 |
Nimbus Apollo, Inc. |
Inhibiteurs de l'acc et utilisations associées
|
JP2016522241A
(ja)
|
2013-06-21 |
2016-07-28 |
ノヴォ ノルディスク アー/エス |
インスリンで治療された及び/又は1型糖尿病に罹患している患者におけるglp−1受容体作動薬の新規の使用
|
BR112015032875A2
(pt)
|
2013-07-04 |
2017-11-07 |
Novo Nordisk As |
derivados de peptídeos do tipo glp-1, e usos dos mesmos
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
CN103405753B
(zh)
|
2013-08-13 |
2016-05-11 |
上海仁会生物制药股份有限公司 |
稳定的促胰岛素分泌肽水针药物组合物
|
WO2015155151A1
(fr)
|
2014-04-07 |
2015-10-15 |
Novo Nordisk A/S |
Composés glp -1 à double acylation
|
AR100942A1
(es)
|
2014-06-25 |
2016-11-09 |
Glaxosmithkline Llc |
Composiciones y método para el control glucémico que comprenden albiglutida
|
WO2016001862A1
(fr)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Formulations à libération prolongée d'insulines
|
WO2016038521A1
(fr)
|
2014-09-08 |
2016-03-17 |
Sun Pharmaceutical Industries Limited |
Compositions pharmaceutiques de liraglutide
|
EP3226906B1
(fr)
*
|
2014-11-27 |
2019-06-12 |
Novo Nordisk A/S |
Dérivés glp-1 et leurs utilisations
|
CN105777872B
(zh)
*
|
2014-12-16 |
2019-06-07 |
深圳翰宇药业股份有限公司 |
一种萨摩鲁肽的纯化方法
|
WO2016180353A1
(fr)
|
2015-05-13 |
2016-11-17 |
杭州九源基因工程有限公司 |
Formulation pharmaceutique comprenant un analogue du glp-1 et son procédé de préparation
|
AR105284A1
(es)
|
2015-07-10 |
2017-09-20 |
Sanofi Sa |
Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
|
EP3423481B1
(fr)
|
2016-03-03 |
2020-10-07 |
Novo Nordisk A/S |
Dérivés glp-1 et leurs utilisations
|
EP3448416B1
(fr)
|
2016-04-28 |
2022-08-10 |
Novo Nordisk A/S |
Semaglutide dans des états cardio-vasculaires
|
WO2018096460A1
(fr)
|
2016-11-22 |
2018-05-31 |
Biocon Research Limited |
Compositions pharmaceutiques d'analogues de glp-1
|
GB201621987D0
(en)
|
2016-12-22 |
2017-02-08 |
Archer Virgil L See Archer Sheri A Arecor Ltd |
Novel composition
|
JP2020514407A
(ja)
|
2017-01-24 |
2020-05-21 |
マクリーゲン, インク.Macregen, Inc. |
アポリポプロテイン模倣物を用いる加齢黄斑変性と他の眼疾患の治療
|
PL3474820T3
(pl)
|
2017-08-24 |
2024-05-13 |
Novo Nordisk A/S |
Kompozycje glp-1 i ich zastosowania
|
AR114162A1
(es)
|
2017-12-21 |
2020-07-29 |
Sanofi Sa |
Composición farmacéutica líquida
|
TWI705820B
(zh)
|
2018-06-22 |
2020-10-01 |
美商美國禮來大藥廠 |
Gip/glp1促效劑組合物
|
KR20210024082A
(ko)
|
2018-06-25 |
2021-03-04 |
제이씨알 파마 가부시키가이샤 |
단백질 함유 수성 액제
|
EP4106724A1
(fr)
|
2020-02-18 |
2022-12-28 |
Novo Nordisk A/S |
Compositions de glp-1 et leurs utilisations
|